SUMMARY To define the range of cardiac involvement in the Churg-Strauss syndrome, M mode, continuous wave Doppler, and cross sectional echocardiograms were recorded in twelve patients with the disorder. The M mode recordings were digitised and the cross sectional images were recorded with standardised gain settings to determine regional myocardial echo amplitude. Left ventricular end diastolic and end systolic dimensions were increased above the normal 95% confidence interval in four patients, three of whom showed a depressed shortening fraction. Mitral regurgitation was present in six patients; this was severe enough to need valve replacement in two. Mean echo amplitude in both the septum and the posterior wall was significantly increased above normal by a mean (SD) of4-87 (2-57) dB, suggesting the presence ofmyocardial fibrosis. There was no evidence of subendocardial involvement as there is in other hypereosinophilic syndromes.
The Churg-Strauss syndrome is recognised by the combination of blood eosinophilia, eosinophilic tissue infiltration, extravascular fibrinoid necrotising (allergic) epithelioid and eosinophilic granuloma formation, and disseminated necrotising vasculitis occurring in asthmatic patients.' 2 Lanham et al noted that "the histological components of the syndrome often do not coexist temporally or spatially" and suggested that the clinical pattern of a prodromal phase of allergic disease, followed by a second phase characterised by eosinophilic tissue infiltration and peripheral blood eosinophilia culminating in a third vasculitic phase, should supercede strict adherence to histopathological criteria for the purposes of diagnosis.' Myocardial fibrosis, particularly in the subendocardial region, is a characteristic feature of the idiopathic hypereosinophilic syndrome4 and it has been attributed directly to the eosinophilia itself. Possible cardiac involvement in patients with ChurgStrauss syndrome and comparable blood eosinophilia, however, is less well defined. We therefore studied a series of patients with Churg-Strauss syndrome by M mode, continuous wave Doppler, and cross sectional echocardiography to assess whether they were also at risk for heart disease.
Requests for reprints to Dr J M Morgan, National Heart Hospital, London WIM 8BA.
Accepted for publication 6 April 1989 Patients and methods
We studied 12 Cardiac involvement in Churg-Strauss syndrome shown by echocardiography posterior wall. We took care to limit sampling to these areas on the myocardium itself and to avoid specular echoes from the endocardium or epicardium. In each region approximately 300 pixels were included within the area of interest. From each the distribution of pixel intensity in each of the 64 grey scale levels was displayed as a histogram, and printed separately. Mean and median pixel levels for each region were calculated.
M mode echocardiograms were recorded under cross sectional control from the level of the tips of the mitral leaflets at a paper speed of 100 m/s with a simultaneous phonocardiogram and electrocardiogram. They showed clear, continuous echoes from the left side of the septum and the endocardial surface of the posterior wall. M mode echocardiograms were digitised,6 and the following measurements were made: (a) maximum and minimum cavity diameter; (b) fractional shortening; (c) septal and posterior wall thickness; (d) percentage increase in posterior wall thickness during systole; (e) peak rate of change of cavity dimension during systole and diastole; and (t) peak rate of change of posterior wall thickness during systole and diastole.
Continuous wave Doppler cardiograms were recorded from the apex with a Doptek Spectrascan along with a simultaneous phonocardiogram and electrocardiogram. The aim was to detect the presence or absence or the typical flow-velocity signal of mitral regurgitation. If it was present, we Inspection of the colour encoded images showed no regional increase in echo amplitude (fig 2) . In Highest level ofpixel intensity is white (see scale). ..1-.
T group.bmj.com on April 7, 2017 -Published by http://heart.bmj.com/ Downloaded from Cardiac involvement in Churg-Strauss syndrome shown by echocardiography addition, there was no significant difference in amplitude between any of the four sites sampled in the patients, indicating that the distribution of the increase was generalised rather than localised.
Discussion
The relation between blood eosinophilia and heart disease is well recognised.489 Endomyocardial fibrosis is prominent in the hypereosinophilic syndrome and leads to a characteristic clinical picture of restrictive cardiomyopathy accompanied by atrioventricular valve regurgitation when the papillary muscles are affected.410 There is much evidence to suggest that these cardiac abnormalities are the direct result of eosinophilia and that they persist even if the eosinophilia itself has subsided.41' Thus Chew et al reported eleven cases of subendocardial fibrosis in patients presenting with restrictive cardiomyopathy, although in only two was there documented eosinophilia.'2
The Churg-Strauss syndrome is distinguished from other causes of hypereosinophilia by specific clinical and histopathological features. Asthma is common but, unlike polyarteritis nodosa, renal involvement is unusual.23 Histologically a disseminated necrotising vasculitis affects the small arteries and veins, together with necrotising (allergic) epithelioid and eosinophilia granulomas. Despite the frequent occurrence of eosinophilia, the possibility that clinically significant heart disease might occur in the Churg-Strauss syndrome has received little attention in published reports, even in the original description of cardiac involvement' and was not considered in the large series reported by Chumbley et al,' despite the frequency of heart disease at necropsy.
More recently, Spry et al noted the presence of diffuse myocardial fibrosis in Churg-Strauss syndrome'3 and extensive replacement of the myocardium by granulomas and scar tissue has been reported.'4 Furthermore, Lanham et al notedthat cardiac involvement accounted for death in 48% of patients with the condition. 3 Davison et al also drew attention to cardiac disease in three patients (included in our series), two ofwhom had evidence of pericardial involvement and one with additional myocardial disease.'5 It was for this reason that the present, more comprehensive investigation was undertaken, by non-invasive methods that have proved effective in detecting cardiac involvement in other forms of heart disease associated with hypereosinophilia. Regional echo amplitude has previously been shown to correlate with myocardial collagen content in chronic heart disease.'6 The method has been used to show localised fibrosis in patients with tropical endomyocardial disease and in endomyocardial fibrosis," 18 especially when it affects the subendocardium and papillary muscles. We found an increase in myocardial echo amplitude in all the patients we studied. But this differed from what we saw in other patients with hypereosinophilia in having a generalised distribution. Theoretically, it might have been caused by myocardial oedema, which we have previously shown to be a cause of increased myocardial echo intensity when it is associated with acute rejection in the transplanted heart.'9 We think that this is an unlikely cause in the present patients, however, because the increased echo intensities persisted when other acute manifestations of the disease, such as eosinophilia, asthma, and vasculitis, had subsided. We cannot confirm this theory by histology in our patients, because none of them has died and endomyocardial biopsy in one patient yielded an inadequate sample. Nevertheless, we conclude that the increase in myocardial echo intensity reflects the generalised increase in myocardial collagen content as found in previous histological studies.
We were also able to study the effects of this fibrosis on left ventricular function. The results of M mode digitisation suggested that simple measurements of systolic and diastolic performance were well preserved. Unlike the hypereosinophilic syndrome,8 there was no echocardiographic evidence that the valve cusps were affected. Nevertheless, continuous wave Doppler detected the presence of mitral regurgitation in six of the twelve patients, an unexpectedly high frequency. In two of these patients it was severe enough to require mitral valve replacement, and in two of the remaining four, in whom it was mild, left ventricular cavity size was not increased. It was not possible, therefore, to attribute this regurgitation simply to cavity dilatation. We suggest, rather, that it is the direct consequence of fibrosis of the papillary muscles occurring as part of the more generalised myocardial effects seen in this disease.
We conclude, therefore, that myocardial fibrosis of generalised distribution is a notable, though usually subclinical feature of the Churg-Strauss syndrome. It may result in left ventricular disease or, more characteristically, in mitral regurgitation which is more severe, and which may occur at a smaller cavity size than that seen in association with other types of left ventricular disease. We believe that echocardiography should be performed on all cases of the syndrome to document the presence and extent of heart disease, because in some it may play a prominent part in the clinical manifestations of the condition.
